Skip to content

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

A Comparison of the Intubating Laryngeal Mask FASTRACH™ and the Intubating Laryngeal Mask Ambu Aura-i™

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03109678
Enrollment
80
Registered
2017-04-12
Start date
2011-07-12
Completion date
2012-03-07
Last updated
2017-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Airway Management, Fibreoptic Intubation, Laryngeal Mask Airway

Brief summary

The intubating laryngeal mask Fastrach™ is considered a gold standard for blind intubation as well as for fibreoptic guided intubation via a laryngeal mask. Recently, a single use version of the mask has been introduced. The Fastrach single use laryngeal mask is beng compared to the new, low-priced single use intubating laryngeal mask Ambu Aura-i™.

Detailed description

Eighty patients undergoing general anaesthesia with planned tracheal intubation for elective surgical procedures are enrolled in the study after checking for inclusion and exclusion criteria. Patients are randomised to either LMA group for blind tracheal intubation with either a standard PVC tracheal tube, or a specifically for the LMA Fastrach developed tube, yielding 4 subgroups. After a standardised anaesthesia induction, blind intubation is performed in each study group. Different time intervals are documented, such as time to first adequate lung ventilation, or f.e. time for laryngeal mask placement. A crossover-design is performed after unsuccessful intubation, using the alternate LMA or the other tracheal tube. LMA placement is visualised by fibreoptic control. An estimated success rate for blind intubation of 60% in the Aura-i group versus 90% in the Fastrach group yields a sample size of n= 38. To compensate for dropouts, n=40 subjects are enrolled in each group.

Interventions

DEVICECrossover Ambu Aura-i™ / Rüsch Super Safety Silk™

After unsuccessful blind intubation in the Ambu Aura-i™ / Rüsch Super Safety Silk™ group: crossover design using the Ambu Aura-i™ mask in combination with the LMA ETT™ tracheal tube

DEVICECrossover Ambu Aura-i™ / LMA ETT™

After unsuccessful blind intubation in the Ambu Aura-i™ / LMA ETT group: crossover design using the Ambu Aura-i™ mask in combination with the Rüsch Super Safety Silk™ tracheal tube

DEVICECrossover FASTRACH™ / Rüsch Super Safety Silk™

After unsuccessful blind intubation in the FASTRACH™ / Rüsch Super Safety Silk™ group: crossover design using the FASTRACH™ mask in combination with the LMA ETT™ tube

DEVICECrossover FASTRACH™ / LMA ETT™

After unsuccessful blind intubation in the FASTRACH™ / LMA ETT™ group: crossover design using the FASTRACH™ mask in combination with the Rüsch Super Safety Silk™ tube

Sponsors

University of Kiel
CollaboratorOTHER
Asklepios Kliniken Hamburg GmbH
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
DEVICE_FEASIBILITY
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients undergoing planned general anaesthesia * planned tracheal intubation * elective surgical procedure * 15 to 80 years of age

Exclusion criteria

* ASA physical status IV and V * severe pulmonary comorbidity (COPD GOLD \>III, bronchial asthma) * indication for rapid-sequence induction * mouth opening (interincisor distance) \<3cm * morbid obesity (BMI \>35kg.m-2)

Design outcomes

Primary

MeasureTime frameDescription
success rate of blind intubationthrough study completion; time frame for individual study patient: two attempts of blind tracheal intubation peri-interventional, time maximum of 300 secondsoverall success rate of blind tracheal intubation within two attempts using either the FASTRACH™ laryngeal mask or the Ambu Aura-i™ laryngeal mask

Secondary

MeasureTime frameDescription
influence of tracheal tubesthrough study completion; time frame for individual study patient: two attempts of blind tracheal intubation peri-interventional, time maximum of 300 secondsinfluence of success rates of blind tracheal intubation using different tracheal tubes (Rüsch or LMA-ETT)
equivalence of the laryngeal masks regarding fibreoptic visualisationthrough study completion; after placing the laryngeal mask and checking for airway leak pressure, fibreoptic visualisation is performed within 60 secondsfibreoptic control of laryngeal mask placement (Fastrach and Aura-i); the position of the larynx relative to the laryngeal cuff and mask-aperture is visualised and categorised as correct, lateral deviation, epiglottic downfolding or not assessable; additionally, the view on the larynx comparable to Cormack/Lehane score is recorded
subjective handling scorethrough study completion; the handling of the laryngeal masks during the first placement attempt within 60 seconds; directly after placing laryngeal masks and before fibreoptic visualisation, the subjective handling score is documented as abovesubjective handling score for the two compared laryngeal masks, rated as excellent (1) - poor (4)
differences in airway leak pressurethrough study completion; right after placing the laryngeal mask and checking for correct positioning, ALP is documented within 60 secondsdifferences in airway leak pressure (ALP) of the two compared laryngeal masks, in cm H2O; presence of audible leakage as well as the absence of corresponding pressure increase on the monitor recorded by setting the APL valve to 40cm H2O, and fresh gas flow at 3l/min
incidence of postoperative sore throat and hoarsenesspatient interview 24 hours post proceduralincidence of postoperative sore throat and hoarseness as well as difficulty swallowing as reported by the study patients (none, moderate, severe)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 3, 2026